Home > Boards > US OTC > Cannabis > Mansfield-Martin Exploration Mng Inc. (MCPI)

CARROLLTON, TX / ACCESSWIRE / January 26, 2015 /

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
hrose Member Profile
Followed By 0
Posts 6
Boards Moderated 0
Alias Born 03/03/15
160x600 placeholder
Blockchain's Revolutionary Potential Goes Well Beyond Just Bitcoin Cryptocurrency "InvestorsHub NewsWire" - 1/4/2018 9:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 10/31/2017 11:00:19 AM
Amended Quarterly Report (10-q/a) "Edgar (US Regulatory)" - 9/26/2017 2:32:34 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 9/22/2017 2:55:09 PM
MJAC 2017 Speaker Update - How venture capital and cryptocurrency are converging as the future of cannabis investing "InvestorsHub NewsWire" - 8/30/2017 10:29:33 PM
PotNetwork Holdings, Inc Confirmed for MJAC 2017 "InvestorsHub NewsWire" - 8/28/2017 10:43:55 AM
MJAC 2017 International Cannabis Conference - Discount Code "InvestorsHub NewsWire" - 8/25/2017 6:50:56 PM
Book your ticket now for InvestorsHubs International Cannabis Conference "InvestorsHub NewsWire" - 8/23/2017 12:50:25 PM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 8/23/2017 12:43:40 PM
MJAC 2017 - Speaker Update - Investing In The U.S. Cannabis Market "InvestorsHub NewsWire" - 8/22/2017 1:27:13 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 8/16/2017 6:03:31 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/29/2017 2:21:57 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/18/2017 1:32:21 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 5/15/2017 5:17:59 PM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 4/19/2017 2:09:26 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 4/17/2017 2:35:21 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/14/2017 11:38:12 AM
Notification That Annual Report Will Be Submitted Late (nt 10-k) "Edgar (US Regulatory)" - 3/31/2017 10:15:24 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/23/2017 3:46:46 PM
Proxy Statement - Other Information (preliminary) (pre 14c) "Edgar (US Regulatory)" - 2/14/2017 2:11:25 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/14/2017 2:10:09 PM
hrose   Tuesday, 03/03/15 06:35:32 PM
Re: None
Post # of 3853 
CARROLLTON, TX / ACCESSWIRE / January 26, 2015 /
Med-Cannabis Pharma, Inc. (MCPI) is is pleased to announce new additions and plans for the New Year, 2015. At the close of 2014, MCPI embarked on a new Joint Venture with Royal Tree Organics to begin a new premier medical marijuana grow facility to produce high quality medicine to market at two of its dispensaries in the state of Oregon. Now at the beginning of the new year MCPI has acquired a new medical marijuana license in the state. This new license creates the opportunity for continued expansion in the market via the opening of an additional dispensary. Currently, MCPI is in the process of building out lease space for occupancy of the dispensary focusing on the area of the Oregon Coast. This location will enhance our ability to bring high quality medicine to market and increase our visibility throughout the state of Oregon. This is in addition to the two dispensaries with currently operating licenses acquired by MCPI last year. By investing in acquiring new licenses MCPI will be able to plan ahead concerning the creation of more dispensaries, which once completed and occupied will have the advantage of an already acquired license. This will allow the dispensaries to begin operation quickly, and decrease the wait time for revenue generation for the company.

In addition to looking forward, the joint venture with Royal Tree Organics remains a high priority and MCPI has already taken steps to ensure its success. Royal Tree Organics (RTO) and its founders Chad Holland and Bryce Davis have the growing and operational expertise and proven track record to produce a high quality medical marijuana product, and MCPI through investments and the joint venture with RTO have begun the crucial step of identifying and procuring a location for the Joint Venture Grow Facility in Oregon. Currently MCPI is in negotiations to finalize the space and location to host the premier grow facility to be operated by the Joint Venture. It is a vital step in realizing the goal of producing the best product to bring to market and is invaluable in light of the acquisition of the new medical marijuana license. As dispensaries and licenses to operate and sell in Oregon increase, the impact of the Joint Venture with RTO will be vital for providing the type of medicinal marijuana that patients need and want. MCPI’s additions in the two key areas of the medical marijuana industry, grow facility and licensed dispensaries will work hand in hand by allowing MCPI to control its business growth and viability in the market without having to be dependent on outside suppliers and dispensaries to generate revenues and returns on investments. In the new year, you can expect to see MCPI and its partners such as RTO to take continued steps to achieving the highest degree of control and certainty in the industry through focused work on its grow facility and expansion of licensed dispensaries in Oregon to sell MCPI’s own superior product.

In anticipation of the company growth, President, Graciela Moreno said “2015 should be very exciting for anyone involved with MCPI!”

Forward Looking Statements:
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. The Company does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist